ARCHIVES

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982

House Members Urge FDA to Review Fast Track Policies

July 5, 2002

Royston Retires At Kimmel; Cancer Care Gives Awards.

June 22, 2001

Cold Spring Harbor Joins SWOG, Becoming First Lab To Join Cooperative Group

November 4, 2011

DeVita Recommends Carcinogenesis Testing Program Be Moved to NIEHS

May 23, 1980